(S)-3-(1-AMINO-ETHYL)-PHENOL CAS:123982-81-0

(S)-3-(1-AMINO-ETHYL)-PHENOL

Chemical Name:   (S)-3-(1-AMINO-ETHYL)-PHENOL
CAS.NO:  123982-81-0
Synonyms:
S-3-Hydroxy-Alpha-methylbenzylamine

Molecular Formula:C8H11NO
Molecular Weight:137.17900

Physical and Chemical Properties:
Density: 1.096g / cm3
Boiling point: 266.3ºC at 760 mmHg
Melting point: /
Flash point: 114.9ºC
Refractive index: 1.572

Specification:
Appearance: white like or light brown crystalline powder
Purity:≥97%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Rivastigmine tartrate CAS:129101-54-8
Intermediates of Rivastigmine CAS:123441-03-2



We are professional (S)-3-(1-AMINO-ETHYL)-PHENOL manufacturer and S-3-Hydroxy-Alpha-methylbenzylamine supplier in China, We offer quality (S)-3-(1-AMINO-ETHYL)-PHENOL you can fully trust, also we have India factory and producer of S-3-Hydroxy-Alpha-methylbenzylamine,Pls send inquiry of (S)-3-(1-AMINO-ETHYL)-PHENOL CAS:123982-81-0 to info@nbinno.com if you have any interests, thank you!


Related News: The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.4-Bromo-3-nitrobenzotrifluoride CAS:349-03-1 The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform.Clorhidrato de N – ((4-clorometil) -2-tiozolil) guanidina CAS:84545-70-0 When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant.153034-78-7 In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.